These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21531120)

  • 21. A novel point mutation of the FALDH gene in a Japanese family with Sjögren-Larsson syndrome.
    Aoki N; Suzuki H; Ito K; Ito M
    J Invest Dermatol; 2000 May; 114(5):1065-6. PubMed ID: 10792573
    [No Abstract]   [Full Text] [Related]  

  • 22. Interlamellar lipid differences between normal and psoriatic stratum corneum.
    Motta S; Sesana S; Monti M; Giuliani A; Caputo R
    Acta Derm Venereol Suppl (Stockh); 1994; 186():131-2. PubMed ID: 8073812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum of mutations and sequence variants in the FALDH gene in patients with Sjögren-Larsson syndrome.
    Sillén A; Anton-Lamprecht I; Braun-Quentin C; Kraus CS; Sayli BS; Ayuso C; Jagell S; Küster W; Wadelius C
    Hum Mutat; 1998; 12(6):377-84. PubMed ID: 9829906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sjögren-larsson syndrome and crystalline maculopathy associated with a novel mutation.
    Jean-François E; Low JY; Gonzales CR; Sarraf D
    Arch Ophthalmol; 2007 Nov; 125(11):1582-3. PubMed ID: 17998529
    [No Abstract]   [Full Text] [Related]  

  • 25. Ceramide profiling of stratum corneum in Sjögren-Larsson syndrome.
    Arai A; Takeichi T; Wakamoto H; Sassa T; Ito Y; Murase Y; Ogi T; Akiyama M; Kihara A
    J Dermatol Sci; 2022 Sep; 107(3):114-122. PubMed ID: 35973883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome.
    Willemsen MA; IJlst L; Steijlen PM; Rotteveel JJ; de Jong JG; van Domburg PH; Mayatepek E; Gabreëls FJ; Wanders RJ
    Brain; 2001 Jul; 124(Pt 7):1426-37. PubMed ID: 11408337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sjögren-Larsson syndrome: biochemical defects and follow up in three cases.
    Auada MP; Taube MB; Collares EF; Tanaka AM; Cintra ML
    Eur J Dermatol; 2002; 12(3):263-6. PubMed ID: 11978568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sjögren-Larsson syndrome: novel mutations in the ALDH3A2 gene in a French cohort.
    Sarret C; Rigal M; Vaurs-Barrière C; Dorboz I; Eymard-Pierre E; Combes P; Giraud G; Wanders RJ; Afenjar A; Francannet C; Boespflug-Tanguy O
    J Neurol Sci; 2012 Jan; 312(1-2):123-6. PubMed ID: 21872273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sjögren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2.
    Carney G; Wei S; Rizzo WB
    Hum Mutat; 2004 Aug; 24(2):186. PubMed ID: 15241804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes.
    Davis K; Holden KR; S'Aulis D; Amador C; Matheus MG; Rizzo WB
    J Child Neurol; 2013 Oct; 28(10):1259-65. PubMed ID: 23034980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compound heterozygous mutations in the
    Liu YD; Lin HJ; Li CY; Sun GF; Hu XB; Ma MY; Sun Y; Feng BZ; Li QB; Kong QX
    Int J Neurosci; 2020 Nov; 130(11):1156-1160. PubMed ID: 31944864
    [No Abstract]   [Full Text] [Related]  

  • 32. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.
    De Laurenzi V; Rogers GR; Hamrock DJ; Marekov LN; Steinert PM; Compton JG; Markova N; Rizzo WB
    Nat Genet; 1996 Jan; 12(1):52-7. PubMed ID: 8528251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzymatic diagnosis of Sjögren-Larsson syndrome using electrospray ionization mass spectrometry.
    Sanders RJ; Ofman R; Dekker C; Kemp S; Wanders RJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):451-5. PubMed ID: 19124283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype and phenotype variability in Sjögren-Larsson syndrome.
    Weustenfeld M; Eidelpes R; Schmuth M; Rizzo WB; Zschocke J; Keller MA
    Hum Mutat; 2019 Feb; 40(2):177-186. PubMed ID: 30372562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel ALDH3A2 heterozygous mutations are associated with defective lamellar granule formation in a Japanese family of Sjögren-Larsson syndrome.
    Shibaki A; Akiyama M; Shimizu H
    J Invest Dermatol; 2004 Dec; 123(6):1197-9. PubMed ID: 15610535
    [No Abstract]   [Full Text] [Related]  

  • 36. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
    Rizzo WB; Craft DA; Somer T; Carney G; Trafrova J; Simon M
    J Lipid Res; 2008 Feb; 49(2):410-9. PubMed ID: 17971613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incomplete Sjögren-Larsson syndrome in two Japanese siblings?
    Willemsen MA; Rotteveel JJ; Steijlen PM; Wanders RJ
    Dermatology; 1999; 199(2):187-8. PubMed ID: 10559596
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid composition of the superficial stratum corneum cells of pig epidermis.
    Gray GM; White RJ; Williams RH; Yardley HJ
    Br J Dermatol; 1982 Jan; 106(1):59-63. PubMed ID: 7059505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, biochemical, and genetic aspects of Sjögren-Larsson syndrome.
    Cho KH; Shim SH; Kim M
    Clin Genet; 2018 Apr; 93(4):721-730. PubMed ID: 28543186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired Skin Barrier Function Due to Reduced ω-
    Nojiri K; Fudetani S; Arai A; Kitamura T; Sassa T; Kihara A
    Mol Cell Biol; 2021 Sep; 41(10):e0035221. PubMed ID: 34370553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.